close
close

INmune Bio Inc. to Present at Baird 2024 Global Healthcare Conference

Boca Raton, Florida, September 3, 2024 (GLOBE NEWSWIRE) — INmune Bio Inc(NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company focused on developing treatments that harness a patient’s innate immune system to fight disease, today announced that management will participate in its upcoming investor conferences in September and October 2024.

Baird 2024 Global Healthcare Conference